Figure 3.
PTRA attenuated cardiac oxidative stress and improved capillary density. Representative myocardial dihydroethidium (DHE, red) and immunofluorescence staining of CD31, and quantification of myocardial production of superoxide anion (DHE area %) and myocardial capillary density (CD31 area %) (n=6/group each). *p<0.05 vs. Lean+Sham; †p<0.05 vs. MetS+Sham; ‡p<0.05 vs. MetS+RVH.